My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Hematología, Inmunología y Hemoterapia
On-line version ISSN 1561-2996
Abstract
MARCELL RODRIGUEZ, Lelyem; COSTALES ELIZALDE, Delfina; MORERA BARRIOS, Luz Mireya and CHANG MONTEAGUDO, Arturo. Risk of viral post-transplant complications in living donor kidney transplant candidates. Rev Cubana Hematol Inmunol Hemoter [online]. 2022, vol.38, n.3 Epub Sep 01, 2022. ISSN 1561-2996.
Introduction:
Living donor kidney transplant is promoted in our country and the rest of the world. The definition of Cytomegalovirus (CMV) and Epstein Barr virus (EBV) post-transplant complications risk is part of pretransplant compatibility tests.
Objective:
To assess post-transplant complication risk with these viruses in Cuban candidates to living donor kidney transplant.
Methods:
Detection of IgG anti-CMV and IgG anti-EBV antibodies by enzyme-linked immunoabsorbent assay was performed on 301 receptors and 390 living donors’ serum examples received, from July 2013 to July 2019, at the Histocompatibility department of the Institute of Hematology and Immunology.
Results:
In candidates to living donor kidney transplant, EBV seroprevalence was greater than CMV’s and increased with age. The 100% of AB blood group had CMV and EBV. There was no association between IgG anti-CMV and IgG anti-EBV antibodies and anti-HLA antibodies, age, gender, skin color, blood group, hepatitis B and C, dialysis type, previous transplants, and transfusions. The 7.3% of patients were labeled as post-transplant complications high risk.
Conclusions:
The seroprevalence of CMV and EBV in living donor kidney transplant Cuban candidates is high, that´s why patients with high risk for post-transplant complications due to these viruses are a few.
Keywords : anti-Cytomegalovirus antibodies; anti-Epstein Barr virus antibodies; living donor; kidney transplant..